Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)

Vansteenkiste, JF; Naidoo, J; Faivre-Finn, C; Ozguroglu, M; Villegas, A; Daniel, D; Murakami, S; Hui, R; Lee, KH; Cho, BC; Kubota, K; Taboada, M; Wadsworth, C; Dennis, PA; Antonia, SJ

ANNALS OF ONCOLOGY, 2019; 30 (): 592